Kv4 (Shal) potassium channels are responsible for the transient outward K ϩ currents in mammalian hearts and central nervous systems. Heteropoda toxin 2 (HpTx2) is an inhibitor cysteine knot peptide toxin specific for Kv4 channels that inhibits gating of Kv4.3 in the voltage-dependent manner typical for this type of toxin. HpTx2 interacts with four independent binding sites containing two conserved hydrophobic amino acids in the S3b transmembrane segments of Kv4.3 and the closely related Kv4.1. Despite these similarities, HpTx2 interaction with Kv4.1 is considerably less voltage-dependent, has smaller shifts in the voltage-dependences of conductance and steady-state inactivation, and a 3-fold higher K d value. Swapping four nonconserved amino acids in S3b between the two channels exchanges the phenotypic response to HpTx2. To understand these differences in gating modification, we constructed Markov models of Kv4.3 and Kv4.1 activation gating in the presence of HpTx2. Both models feature a series of voltagedependent steps leading to a final voltage-independent transition to the open state and closely replicate the experimental data. Interaction with HpTx2 increases the energy barrier for channel opening by slowing activation and accelerating deactivation. The greater degree of voltage-dependence in Kv4.3 occurs because it is the voltage-dependent transitions that are most affected by HpTx2; in contrast, it is the voltage-independent step in Kv4.1 that is most affected by the presence of toxin. These data demonstrate the basis for subtype-specificity of HpTx2 and point the way to a general model of gating modifier toxin interaction with voltage-gated ion channels.
Introduction
Potassium currents with fast activation and inactivation kinetics are present in many mammalian tissues and are often conducted by the three members of the Shal (Kv4) family of voltage-gated K ϩ channels (Birnbaum et al., 2004) . These channels are best known for their key roles in cardiovascular and nervous systems. Kv4.2 and Kv4.3 are the pore-forming channel subunits of the fast-recovering cardiac transient outward current that is most prominently found in the atria, right ventricle, and left ventricular epicardium of many mammals, in which their prominent role in early repolarization influences calcium current magnitude and myocardial contractility (Nerbonne and Kass, 2005) . In neurons, they are responsible for the I A K ϩ current in the somatodendritic region, which limits the amplitude and accelerates the decay of excitatory postsynaptic action potentials and inhibits back propagation of depolarization in dendrites (Covarrubias et al., 2008) . A physiological role for the third member of the family, Kv4.1, has not been clearly established.
The sequences of the three Kv4 channels are highly conserved: there is 87% sequence identity between voltage sensor and pore domains of Kv4.3 and Kv4.1, and 95% between Kv4.3 and Kv4.2. As expected from channels with this level of conservation, they share many gating properties. In heterologous expression systems, their conductance-voltage relationships are best described by a Boltzmann function with midpoints (V 1/2 ) near 0 mV; activation and deactivation are fast compared with most other voltage-gated K ϩ channels (Birnbaum et al., 2004) . Inactivation of Shal channels is a complex and relatively slow process occurring from multiple open and closed states (Bä hring and Covarrubias, 2011) .
Potassium currents generated by Shal channels in vivo have been identified using the closely related peptide toxins HpTx2 and HpTx3 (Sanguinetti et al., 1997; Brahmajothi et al., 1999; Himmel et al., 1999; Kassiri et al., 2002; Ramakers and Storm, 2002; Varga et al., 2004; Nerbonne et al., 2008; Liu et al., 2011) . The best characterized is HpTx2, a 30-amino acid toxin originally purified from the venom of the spider Heteropoda venatoria (Sanguinetti et al., 1997) . It is one of more than 300 known ion-channel peptide toxins that form an "inhibitor cysteine knot" (ICK) motif, most of which have been identified in spider venom (Gracy et al., 2008) . Both in vivo data and our studies using heterologously expressed channels have strongly suggested that HpTx2 is specific for Kv4 channels (Zarayskiy et al., 2005) . HpTx2 inhibition of Kv4.3 was voltage-dependent, shifting the threshold for activation to more depolarized potentials, speeding deactivation, and slowing inactivation (Zarayskiy et al., 2005) . Alanine scanning mutagenesis showed that HpTx2 interacts with two amino acids in the S3b TMS of the VSD (DeSimone et al., 2009) . These characteristics established HpTx2 as a gating modifier toxin that inhibits the channel by interfering with the movement of the voltage sensor domain during gating.
In contrast to Kv4.3, the HpTx2-induced gating modification of Kv4.1 was much less voltage-dependent (Zarayskiy et al., 2005) . This surprising observation led us to compare the interaction between HpTx2 and these two channels. In this study, we show that Kv4.1 and Kv4.3 share a binding site for HpTx2 in the S3b TMS, ruling out an entirely different mechanism of gating modification for the two channels. We found that the molecular basis of differences in voltage-dependent inhibition were due to a nonconserved four-amino acid region in S3b adjacent to the toxin's putative binding site. To gain insights into the mechanism responsible for differences in HpTx2 gating modification, we developed Markov models of Kv4.1 and Kv4.3 activation in the presence of HpTx2. In the absence of toxin, we propose five closed states leading to an open state. The transitions between the closed states are voltage-dependent, whereas the transition from the final preopen closed to the open state is voltageindependent. To account for HpTx2 interaction, we added four toxin-bound states and the transition rates to account for experimentally observed toxin-dependent effects. The model suggests that HpTx2 primarily effects the voltagedependent transitions in Kv4.3, resulting in a high degree of voltage-dependent inhibition by HpTx2. In contrast, the toxin stabilizes the final preopen closed state of Kv4.1. Because this transition is voltage-independent, there is a lower degree of voltage dependence of HpTx2-induced gating modification. These experiments show that subtle differences in the gating properties of two closely related K ϩ channels can result in large differences in gating modification by toxins or drugs that have similar molecular basis of interaction with their ion channel targets.
Materials and Methods
Preparation of RNA for Oocyte Injection. The short form of rat Kv4.3 (636 amino acids; National Center for Biotechnology Information accession number NP_113927), and the mouse Kv4.1 (NP_032449) were described previously (Wang et al., 2002; Zarayskiy et al., 2005) . Site-directed mutagenesis was performed as described previously (DeSimone et al., 2009) ; mutant identity was confirmed by DNA sequencing. Plasmids encoding cloned channels were linearized by restriction endonuclease digestion and transcribed using T7 RNA polymerase (mMessage Machine; Ambion, Austin, TX). The reaction was terminated by DNAase I treatment followed by precipitation of RNA with LiCl and suspension in RNAase-free water included in the mMessage Machine kit. The sample concentration was determined by absorbance at 260 nm, adjusted to 500 ng/ml, and stored at Ϫ80°C.
Xenopus laevis Oocyte Preparation. Use of X. laevis has been considered and approved for numbers of animals, humane treatment, care, and method of euthanasia by the University at Buffalo-SUNY Institutional Animal Care and Use Committee and was carried out in accordance with the Declaration of Helsinki and with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) as adopted and promulgated by the U.S. National Institutes of Health (Bethesda, MD).
Oocytes were prepared as described previously (DeSimone et al., 2009) . Frogs obtained from Xenopus I (Ann Arbor, MI) were anesthetized by immersion in 2.0 mM 3-aminobenzoic acid ethyl ester (Sigma-Aldrich, St. Louis, MO) for at least 10 min. The ovarian lobes were harvested and placed in Ca 2ϩ -free ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , and 5 mM HEPES, pH 7.4) and treated with 1 to 2 mg/ml collagenase (type II; Sigma-Aldrich) to remove the follicular cell layer. Oocytes were injected with 10 to 50 nl of in vitro-transcribed mRNA. Injected oocytes were incubated at 18°C in normal ND96 (including 1.8 mM CaCl 2 ) plus antibiotic/antimycotic (Invitrogen, Carlsbad, CA) for 3 to 7 days. Two-Electrode Voltage-Clamp Technique. Currents were measured in oocytes using a two-microelectrode Dagan CA-1B amplifier as described previously (Wang et al., 2004; Wang et al., 2005) . Electrodes were filled with 3 M KCl. Experiments were performed at room temperature (20-24°C), or at 16°C where noted, in either ND96 plus 0.1% bovine serum albumin or 98K plus 0.1% bovine serum albumin (98 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , and 5 mM HEPES, pH 7.4). For experiments performed at 16°C, a Dagan HCC-100 temperature controller was used to regulate both the recording chamber and solution temperatures. Data were digitized at either 50 or 5 kHz using Clampex 9.2 (Molecular Devices, Sunnyvale, CA), and analyzed with Clampfit 9.2, Microsoft Excel 2007 (Microsoft, Redmond, WA), or SigmaPlot 9 (Systat Software, Inc., San Jose, CA). Raw current traces shown were neither leakage-nor capacitance-subtracted.
Pulse Protocols and Data Analysis. The holding potential for all pulse protocols was Ϫ90 mV. A two-pulse protocol was used to measure the current-voltage (I-V), conductance-voltage (G-V), steady-state inactivation (SSIA) relationships, and time to peak current. From the holding potential, 3-s voltage steps (P1) were applied from Ϫ120 to ϩ50 mV in 10-mV increments followed by a 1-s pulse (P2) to ϩ50 mV, with a 3-s interval before the next P1 pulse. Normalized current (I/I max ) was calculated as the ratio of the maximum current during the P1 pulse to the maximum current during the 50-mV P1 pulse before application of HpTx2. Conductance G(V) at each voltage was calculated from the equation G(V) ϭ I max,1 /(V Ϫ E K ), where V is the depolarization voltage during P1, I max,1 is the maximum current during P1, and E K ϭ Ϫ100 mV, the reversal potential of K ϩ for X. laevis oocytes in ND96. The G-V relationship was obtained by fitting G(V), normalized to the maximal conductance value, with a Boltzmann function
, where V 1/2 , k, and G max are the half-activation potential, the slope factor, and 1.0, respectively. Steady-state inactivation was determined as the ratio of the maximum current during P2, I max,2 for the P1 depolarization voltage to the maximum value of I max,2 . The voltage dependence of steady-state inactivation relationships were fitted by the Boltzmann function
where V 1/2,i and k i are the half-inactivation potential and the slope factor, respectively. Association/dissociation experiments (Figs. 2A and 3, J and K) were performed with a two-pulse protocol: the P1 pulse was to Ϫ10 mV for 12 ms, followed by a P2 pulse to Ϫ50 mV for 150 ms, with a 1-s interpulse interval. The data represent the normalized reciprocal current amplitude measured from the maximum of the P2 pulse. The on and off rates were fit with the functions ƒ on (t) ϭ C ϫ exp(Ϫt/4 on ) and ƒ off (t) 
, respectively. The dissociation constant (K d ) ϭ k off / k on , where k off ϭ 1/ off , and k on ϭ 1/(4 ϫ [HpTx2] ϫ on ).
Activation was measured using a series of 1000-ms pulses from the Ϫ90-mV holding potential to a series of steps from Ϫ30 to ϩ50 mV in 10-mV increments. The activation time constants were determined by fitting the activation time course to the function f act (t) ϭ
4 . To measure deactivation, the P1 pulse was set to ϩ50 mV for 12 ms, followed by a 150-ms P2 pulse from Ϫ120 to Ϫ40 mV in 10-mV increments. Deactivation time constants were determined by fitting the currents in the P2 pulse to the function
Model Development. Model development was performed on a DEC Alpha workstation using Fortran 90. The Markov model was implemented as a set of evolution differential equations for five closed states, C 0 to C 4 , and one open state, O. The numerical solution of differential equations was performed by a fourth-order RungeKutta method. Channel models were allowed to run for at least 600 s to calculate the steady-state values of occupancies of channel states and were used as the initial conditions (Wang et al., 2004) .
Results
Gating Modification of Kv4.1 by HpTx2. Peptide toxins have found wide use as structural probes for ion channels and as pharmaceutical agents (Lewis and Garcia, 2003; Catterall et al., 2007; Estrada et al., 2007; Swartz, 2007; Hodgson and Isbister, 2009; Dutertre and Lewis, 2010) . Their interaction with ion channels falls into two general classes: pore blockade, or gating modification. Pore-blocking toxins bind to the pore region of a channel and prevent permeation of ions through occlusion of the external channel pore. Gating modifier toxins inhibit or activate ion channel conductance by interfering with the energetics of channel gating (Catterall et al., 2007; Swartz, 2007) .
A hallmark of gating modifier toxin activity on voltagegated K ϩ channels is voltage-dependent inhibition; there is a greater degree of channel inhibition at voltages near the activation threshold (Swartz and MacKinnon, 1995) . This effect can be seen by comparing the I-V relationships of Kv4.3 in the presence and absence of 2 M HpTx2 (Fig. 1A) . Note that at voltages less than 0 mV, there is a much greater degree of channel inhibition than at higher voltages, indicating strong voltage-dependent inhibition. Kv4.1 is a close relative of Kv4.3, with more than 90% amino acid identity from the beginning of S1 to the end of S6. However, inhibition of Kv4.1 by HpTx2 exhibited less voltage dependence (Fig. 1B) . For example, at 0 mV, 80% of the Kv4.3 current is inhibited, whereas Kv4.1 current is only reduced by half. In contrast, at ϩ50 mV, 2 M HpTx2 inhibits both channels to nearly the same degree: 38% of Kv4.3 current is inhibited versus 36% of the Kv4.1 current (Fig. 1, A-D) . This manifests itself in relatively feeble shifts in the normalized G-V relationship when toxin is applied to Kv4.1; the change in voltage at one half-the maximum normalized conductance (⌬V 1/2 ) values are 22.0 Ϯ 1.6 and 10.2 Ϯ 1.2 mV for Kv4.3 and Kv4.1, respectively (Fig. 1 , E and F, and Kv4.3 and Kv4.1 also showed differences in their apparent affinity for HpTx2. To determine the gating modification kinetics and apparent dissociation constant we used a method described in detail elsewhere (Swartz and MacKinnon, 1997; DeSimone et al., 2009 ). In brief, we used a two-pulse protocol from our previously determined threshold depolarization voltages of Ϫ10 to Ϫ50 mV at 1-s intervals. The bath solution contained 98 mM K ϩ to ensure sufficiently large tail current amplitudes to accurately measure the toxin occupancy. After establishing baseline current amplitude, toxin was applied directly to the chamber. When toxin inhibition reached steady state, the toxin was washed off the oocyte by perfusion ( Fig. 2A) . The time courses of association and dissociation were fit with exponential functions; dissociation was fit with a fourth power exponential function to account for the 4-fold symmetry of Kv4.1, which suggests four HpTx2 binding sites, as was established for HpTx2 interaction with Kv4.3 (DeSimone et al., 2009 ). The K d of HpTx2 was 7.1 Ϯ 1.1 M (Table 2) , roughly 3-fold higher than the 2.3 Ϯ 0.3 M concentration of HpTx2 with Kv4.3.
HpTx2 inhibition of Kv4.3 occurs by gating modification through a putative binding site in S3b (DeSimone et al., 2009) ; however, the relative lack of voltage-dependence observed in the Kv4.1 I-V relationship suggested that HpTx2 might somehow be occluding the pore of this channel. Given the apparent structural similarity between Kv4.1 and Kv4.3, this would probably mean that the channels do not share the same toxin binding site, which in turn would suggest a different mechanism of channel inhibition. We found previously that the critical amino acids necessary for toxin-channel interaction in Kv4.3 were a leucine and valine at positions 275 and 276 (DeSimone et al., 2009 ). The amino acids at the analogous positions in Kv4.1 are a leucine and a phenylalanine (Fig. 2B ). Therefore, we constructed Kv4.1 [(L275,F276)A], substituting the two amino acids at positions 275 and 276 with alanine, similar to the modification that nearly eliminates Kv4.3 interaction with HpTx2 (DeSimone et al., 2009) . When expressed in X. laevis oocytes, the mutant Kv4.1 expressed currents similar to the wild-type Kv4.1. However, there is almost complete loss of gating modification after application of 5 M HpTx2 (Fig. 2 , C and D, and Table 1 ). These data show that the putative binding site of HpTx2 is the same in Kv4.3 and Kv4.1, strongly suggesting that the differences in gating modification are due to intrinsic differences in gating between the two channels and not by the location of toxin binding.
Differences in the S3b TMS Account for the Difference in Gating Modification. Although putative binding site differences between Kv4.3 and Kv4.1 do not account for the differences in channel behavior toward HpTx2, other amino acid differences could account for this phenomenon. Aside from the typically nonconserved S1-S2 TMS external linker, the largest stretch of different amino acids in the voltage sensor and pore domains stretches from amino acid Val276 to Asn279 in Kv4.3 and Phe276 to Lys279 in Kv4.1 (Fig. 2B ). Proximity to both the apparent HpTx2 binding site on Kv4.3 and the S4 transmembrane voltage-sensing sequence suggested that these amino acids might be important C and D, representative current traces of Kv4.3 and Kv4.1 in the presence of HpTx2 (gray). Currents were elicited from a holding potential of Ϫ90 to 0 mV for 2.5 s. Scale bars, 0.5 A ϫ 0.5 s. The data were neither leakage-nor capacitance-subtracted. E and F, conductance-voltage relationships of Kv4.3 and Kv4.1 in the presence of HpTx2. G and H, voltage-dependence of steady-state inactivation of Kv4.3 and Kv4.1 in the presence of HpTx2. Note in E and G that Kv4.3 has robust changes in voltage dependence to more depolarized potentials after application of HpTx2, a response characteristic of gating modifier toxins. In contrast, the same concentration of HpTx2 induces relatively feeble voltage-dependent effects in Kv4.1 (see Table 1 ). Fig. 1, A, B , and E-H, with Fig. 3 , B-D and F-H; see Table 1 ). However, application of HpTx2 revealed dramatic differences between the wild-type and mutant phenotypes of the two channels. Kv4.1 [276VMTN] behaves toward 2 M HpTx2 very similarly to wild-type Kv4.3 (Table 1) . Like wild-type Kv4.3, the Kv4.1 S3b mutant has a high degree of voltage sensitivity toward toxin inhibition; 2 M HpTx2 inhibits 39 and 82% of the Kv4.1 [276VMTN] current at 50 and 0 mV, respectively (Fig. 3B) . The behavior of Kv4.1 [276VMTN] ϩ 2 M HpTx2 with respect to G-V is not identical with Kv4.3 but is still much more like Kv4.3 than Kv4.1 (Fig. 3E) (Fig. 3F) . Likewise the ⌬V 1/2 values for G-V and SSIA are all very close: 9.7 Ϯ 0.7 mV and 3.5 Ϯ 0.09 mV for Kv4.3 [276FVPK], compared with 10.2 Ϯ 1.2 mV and 2.3 Ϯ 0.06 mV for Kv4.1, respectively (Fig. 3 , G and H; summarized in Fig.  3I and Table 1 ). This pattern also holds for the kinetics of gating modification and K d (Fig. 3, J Kinetic Modeling of HpTx2 Interaction with Kv4.1 and Kv4.3. The previous experiments allowed us to deduce the molecular basis of the differences in HpTx2-induced gating modification of Kv4.1 and Kv4.3. However, these data do not address the functional basis for these differences. Con- servation of the HpTx2 binding site in the two channels suggests that the answer does not lie in the mechanism of toxin interaction with the channel but in differences of its effect on activation and deactivation of Kv4.1 and Kv4.3.
To test this hypothesis, we took our previously described Markov model of Kv4.3 activation (Wang et al., 2004) , and used experimentally derived data to develop a Markov model of Kv4.1 activation. The Markov model structure for activation in the absence of HpTx2 is described in scheme 1 (Fig. 4A) . It includes four closed states (C 0 -C 3 ), a preopen closed state (C 4 ), and an open state (O). Transitions between the closed states are voltage-dependent. The C 4 to O transition is voltage-independent. Kv4.1 and Kv4.3 have four subunits, and the model assumes that each subunit must be activated before the channel can conduct ions. The model parameters are described in Table 3 .
We obtained the rate constants for Kv4.3 and Kv4.1 model development based on experimental results from the voltage dependence of activation, deactivation, and G/G max . These experiments were performed at 16°C to slow the activation and deactivation rates, which kept signals from being obscured by the capacitance transient, allowing accurate assessment of act and deact (Fig. 5, A and B) . The model simulates the voltage-dependence of act and deact that are well fit to the experimental data (Fig. 5, C-F) . The forward rate constants (␣) and voltage-independent rate constants (k co and k oc ) are the same in both models. Deactivation is slower in Kv4.1 than in Kv4.3 ( deact, Kv4.1 ϭ 7.2 Ϯ 0.3 ms Ϫ1 , and 4.8 Ϯ 0.3 ms Ϫ1 for Kv4.3, both at Ϫ120 mV; Fig. 5 , E and F); to account for this, we reduced the reverse rate constant (␤) by a factor of 0.82 in Kv4.1 (Table 3) .
Because the toxin binding experiments were conducted at room temperature (approximately 21°C), the derived values of the forward (␣) and reverse (␤) rate constants at 16°C were multiplied by the square root of the Q 10 (3.17 Ϯ 0.54) (Campbell et al., 1993) to compensate for temperature differences. This compensation gives similar results obtained during the development of our original Kv4.3 model (Wang et al., 2004) , suggesting that it is valid for Kv4.1 activation as well. To model the effect of HpTx2 on Kv4.1 and Kv4.3, we assumed that one toxin molecule could bind to each subunit and that each subunit activates independently. This results in independent modification of the transition rates for activationdeactivation of toxin-bound subunits. Combining the activation model of scheme 1 (Fig. 4A ) with a kinetic model for toxin binding (Swartz and MacKinnon, 1997) , we constructed a 30-state Markov model for toxin-channel interaction illustrated in scheme 2 (Fig. 4B ). In this model, each closed state can be occupied by up to four toxin molecules. At Ϫ90 mV, HpTx2 binds to the closed state of Kv4 channels; these closed states have four "nonactivated" subunits through the toxin binding pathway from C 0 to CB 04 (see Fig. 2A and DeSimone et al. (2009) ; transitions C 0 to CB 04 in Fig. 4B with rates k on and k off ). This gives the models five subpopulations of channels whose activation pathways can accommodate up to four bound toxin molecules. Activation and deactivation kinetics of the channels are roughly 3 orders of magnitude faster than toxin on and off rates, strongly suggesting that the channels will retain bound toxin in the open state. This is shown in the model as one unbound open state O, and four open states with bound toxin (OB 1 -OB 4 ; Fig. 4B) .
To determine transition rates between states in the Markov model, we used experimental data of the influence of HpTx2 on Kv4.3 and Kv4.1 I-V and G-V relationships and activation and deactivation kinetics. The models postulate that binding of one toxin molecule changes the activation and deactivation rate constants for each channel subunit. For example, when one toxin molecule is bound to the channel, the total transition rate from CB 01 to CB 11 , is ␣ T ϩ 3␣ (Fig.  4B) . There are 12 possible transitions from CB 11 to CB 21 (two activated subunits): 3 with a rate of ␣ T , and 9 with rates equal to ␣, yielding a net transition rate of 3 ⁄4(␣ T ϩ 3␣). Likewise, deactivation rate constants from CB 21 to CB 11 to CB 01 are ␤ T ϩ 3␤ and 1/4(␤ T ϩ 3␤), respectively. Identical reasoning was used to assign the voltage-dependent rate constants to the remainder of the transitions in scheme 2.
The rules are similar for voltage-independent transitions. The modified transition rates for each subunit (k coT and k ocT ), result in the voltage-independent rates 1/4[ik coT ϩ (4 Ϫ i)k co ] and 1/4[ik ocT ϩ (4 Ϫ i)k oc ], where i is the number of toxin molecules bound to the channel. The association and dissociation rates between toxin-bound states with at least one activated subunit were modified to fulfill the conditions of detailed thermodynamic equilibrium. For example, for transitions between CB 11 and CB 12 , coefficients t ␣2 and t ␤2 are defined as Fig. 4B . The rate constants that were changed to account for HpTx2 interaction with Kv4.1 and Kv4.3 are summarized in Table 3 . Application of 2 M HpTx2 increased the time-to-peak current by 10 and 20% at for Kv4.1 and Kv4.3, respectively (Fig. 5, G and H) , making the activation rate constants ␣ T ϭ 0.9␣ for Kv4.1 and ␣ T ϭ 0.8␣ for Kv4.3. Deactivation of both channels accelerated by a factor of 2, so that ␤ T ϭ 2␤ for both Kv4.1 and Kv4.3. To account for the differences in the toxin effect on current-voltage and conductance-voltage relationships (Fig. 1, A-F (Fig. 6A, and Table 1 ). In both cases, the predicted K d is approximately 2-fold lower; however, the affinity constants maintain their relative values with respect to the two channels.
In developing the model, we made minimal changes to the specified parameters based on the experimental data. Changing other gating parameters did not produce a model that fit experimental data. Specifically, changes in rate constants (␣ and ␤) of the voltage-dependent steps of the Kv4.1 activation model created shifts in the normalized G-V relationship that did not fit the experimental data; the changes in k OC were the only variation we found that mimicked the effects of HpTx2.
Likewise, the simulated data of the toxin's influence on the current and conductance-voltage relationships reproduced the experimental data well. The outstanding difference in HpTx2-induced I-V relationships between Kv4.3 and Kv4.1 was the degree of voltage-dependent inhibition. The model predicts that 2 M HpTx2 will inhibit 53% of Kv4.1 K ϩ current at 0 mV and only 31% at 50 mV compared with the experimental data of 54 Ϯ 5 and 36 Ϯ 2%, respectively (Fig.  6B) . For Kv4.3 inhibition at 0 mV, the model predicts 81% compared with the measured value of 80 Ϯ 3% and at 50 mV, 45% compared with the measured value of 37 Ϯ 3% (Fig. 6C) . The ⌬V 1/2 in G/G max for Kv4.1 upon application of 2 M HpTx2 was 10.2 Ϯ 1.2 mV, close to the 16.3 mV predicted by the model. Under the same conditions, Kv4.3 shifts 22.0 Ϯ 1.6 mV, approximately 3 mV less than the predicted 24.9 mV shift (Fig. 6, D and E) . These close approximations suggest that the observed differences in Kv4.1 and Kv4.3 gating upon HpTx2 application are due to differences in modification of the kinetics of both the voltage-dependent and voltage-independent transitions occurring during channel activation and deactivation.
Discussion
Heteropoda toxin 2 is one of many ICK toxins that are voltage-dependent gating modifiers of mammalian voltagegated K ϩ channels (Swartz, 2007) . However, HpTx2 is the first K ϩ gating modifier toxin to show the type of isoformspecific voltage-dependent properties demonstrated by our data. To understand this novel observation, we identified the molecular basis of the differences in gating modification of Kv4.3 and Kv4.1 by HpTx2. We then developed a 30-state Markov model that can account for how the toxin influences the two channels differently. To our knowledge, this is the first detailed study to examine the mechanism of these dif- Fig. 5 . The Kv4 activation model reproduces both Kv4.1 activation and deactivation. A, current traces of activation versus time after pulses to Ϫ30 to ϩ50 mV in 10-mV increments from the Ϫ90 mV holding potential. B, current traces of deactivation from a ϩ50-mV pulse to a range of voltages from Ϫ120 to Ϫ50 mV in 10-mV increments. C and D, simulations of the experiments in A and B. E and F, activation and deactivation time constants for Kv4.1 (E) and Kv4.3 (F) plotted against voltage. The solid lines represent predictions derived from the Kv4 activation models. The experimental data were collected at 16°C, and the simulations were performed with the model parameters adjusted to 16°C (reduction of the rate constants by a factor 1.78 and replacement of T ϭ 295 K by T ϭ 289 K). G and H, time to peak current for Kv4.1 and Kv4.3 in the presence of HpTx2. Protocol is the same as in Fig. 1A , from a holding potential of Ϫ90 mV for Kv4.1 (A; squares) and Kv4.3 (B; circles) 
, where factors f␣ ϭ1/(1 ϩ exp((V ϩ 10.0)/10.0)) and f␤ ϭ1/(1 ϩ exp((V ϩ 5.0)/10.0)), where V is voltage, F is the Faraday constant, R is the gas constant, and T is absolute temperature. Net current through the channel is given by
Kv4. Table 2) . The larger Kv4.1 K d results in a smaller number of toxin-bound channels in the C 01 to C 34 states at any given voltage; therefore, more channels follow the direct activation pathway from C 0 to O. The result is the comparatively small depolarizing shift in Kv4.1 G-V relationship in the presence of toxin. However, Kv4.1 and Kv4.3 are inhibited by toxin to nearly the same degree at ϩ50 mV. To account for this, we increased the toxin-bound voltageindependent rate (k oc ) 2-fold in the Kv4.3 model and 6-fold in the Kv4.1 model, resulting in a more stable Kv4.1 C 4 state. The higher affinity of HpTx2 for Kv4.3 results in greater inhibition during the voltage-dependent steps. Therefore, a smaller decrease in k co gives the same degree of inhibition of Kv4.3 by HpTx2.
The probabilities of finding Kv4.1 and Kv4.3 in the presence of toxin in closed and open states (state occupancies) are illustrated in Fig. 7 . At Ϫ50 mV, lower than the threshold for Fig. 6 . The Kv4 activation models reproduce HpTx2 gating modification. A, time courses of interaction (represented as on and off ), and dissociation constants for Kv4.1 (white) and Kv4.3 (gray) . Open bars represent experimental data as mean Ϯ S.E.M., n ϭ 6, calculated from Fig molpharm.aspetjournals.org activation, both channels are in the C 0 to C 3 states regardless of HpTx2 presence. As the voltage increases to Ϫ10 mV in the absence of toxin, a significant fraction of channels open: 29% of Kv4.1 (Fig. 7A) and 16% of Kv4.3 (Fig. 7B) ; only 7% of Kv4.1 and 4% of Kv4.3 occupy the C 4 state (Fig. 7C) . With the addition of 2 M HpTx2, a negligible number of Kv4.3 channels are in the open and C 4 states at Ϫ10 mV. However, a significant fraction of Kv4.1 channels are open (13%) and in the C 4 (8%) states under these conditions, which is reflected the lower degree of voltage-dependence of HpTx2 interaction with Kv4.1. At ϩ30 mV in the absence of HpTx2, the two channels have approximately the same proportion of open, C 0 to C 3 , and C 4 states. In the presence of toxin, the number of open state channels is decreased in favor of closed states for both channels; however, the fraction of Kv4.1 in C 4 state is 24% compared with only 10% of Kv4.3. The relatively large effect of HpTx2 on the voltage-independent transition from C 4 to O of Kv4.1 results in higher occupation of the C 4 state, thus accounting for the low degree of voltage dependence of HpTx2 modification of Kv4.1 gating.
In developing models to account for the effects of HpTx2 on Kv4.3 and Kv4.1, we restricted ourselves to a description of the toxin's effects on Kv4.3 and Kv4.1 activation. Eliminating inactivation from our models of HpTx2 gating modification is possible because all forms of inactivation in Kv4.1 and Kv4.3 are much slower than activation and deactivation in the presence of HpTx2. These rate differences allow measurement of activation and deactivation at time scales that do not allow significant development of inactivation.
Eliminating inactivation also greatly simplified model development but still allowed us to account for our experimental observations. This is not surprising; aside from the long time constants involved in inactivation, our previous studies showed that HpTx2 has very modest effects on Kv4 inactivation kinetics (Zarayskiy et al., 2005) . Furthermore, the shifts in V 1/2 steady-state inactivation induced by HpTx2 (Fig. 1, G and H) mirror the shifts in V 1/2 calculated from the G-V relationship, the result being a much smaller ⌬V 1/2 for Kv4.1 than for Kv4.3 (⌬V 1/2,SSIA ϭ 2.3 Ϯ 0.06 mV for Kv4.1 and 18.4 Ϯ 2.1 mV for Kv4.3; Table 1 ). This behavior probably reflects the coupling of Kv4 inactivation to activation. Although a full consideration of inactivation in our Markov models might have contributed some insight to Kv4 inactivation, our goal was to understand the differences in behavior observed between Kv4.3 and Kv4.1 in the presence of HpTx2. The success of our model in recapitulating our experimental data argues that the assumptions behind its development (i.e., not including inactivation) are valid and that inactivation is not important to understanding our observations.
Our previous work has shown that the critical amino acids for HpTx2 gating modification of Kv4.3 are a leucine and valine dyad at amino acid 275 in transmembrane segment S3b (DeSimone et al., 2009 ). In Kv4.1, the required amino acids are a conserved leucine and a phenylalanine at the homologous position in S3b (Fig. 2B) . In addition to the binding sites being similar, we have also shown that the number of potential binding sites between the two channels is identical. However, the most striking feature of HpTx2 interaction with Kv4.3 and Kv4.1 is the difference in the degree of voltage sensitive inhibition. We have established that this effect is solely due to four nonidentical amino acids in S3b that overlap with the HpTx2 binding site. Individual point mutations of the four nonconserved amino acids had little effect on voltage dependence, except for P278T (in Kv4.1; data not shown), whose effects were similar but not as dramatic as those of Kv4.3[276FVPK] and Kv4.1[276VMTN], which effectively reversed the gating modification phenotype (Fig. 3) . The existence of proline 278 in Kv4.1 is unique; there are no other occurrences at the homologous position in any known voltage-gated K ϩ channel. The S3b of Kv2.1 forms an ␣ helix through this position (Long et al., 2007) ; however, proline is well known for its inability to fit into internal positions in helices and is most often associated with turns (Richardson and Richardson, 1989) , suggesting that the structure of Shal channel S3b may not be well conserved with Kv2.1.
Gating modifier toxins similar to HpTx2 interact with the outward facing portion of the VSD, sitting between the VSD and the pore domain, in which they are well positioned to interfere with the translational and rotational movement of the VSDs that lead to opening of the channel pore (Milescu et al., 2009; Wee et al., 2010) . The VSD has been implicated in the transition from the voltage-independent preopen closed state (C 4 ) to the open state (Schoppa and Sigworth, 1998; Zandany et al., 2008) . We show that much of the inhibition of Kv4.1 by HpTx2 must be occurring during this final, voltageindependent step, suggesting an important role for S3b movement in the transition. On the other hand, the different S3b sequence of Kv4.1 might allow HpTx2 to interfere with the concerted conformational changes in each pore domain subunit required for channel opening. Although we lack the structural data required to distinguish these hypotheses, we believe that this study emphasizes the unique value of gating modifier toxins in understanding activation kinetics and their relation to voltage-sensor structure and movement in voltage-gated ion channels.
HpTx2 is 1 of 18 peptide toxins reported to interact with a member of the Kv4 family (Herzig et al., 2011) , all of which share the inhibitor cysteine knot tertiary structure and were purified from spider venom. Of these, three others have been shown to discriminate between Kv4.3 (or Kv4.2) and Kv4.1 but not to interact with other voltage-gated channels. Two were purified from the Phrixotrichus auratus venom, PaTx1 and PaTx2, with PaTx1 being the more potent of the two (Diochot et al., 1999) ; these toxins share approximately 50% sequence identity with HpTx2. PaTx1 inhibition of Kv4.3 is similar to that of HpTx2 except that it significantly slows inactivation kinetics and recovery from inactivation. It is also a weaker inhibitor of Kv4.1 currents. In contrast, A toxin 79% identical with PaTx1, JZTX-XII purified from Chilobrachys jingzhao venom, is a relatively strong inhibitor of Kv4.1 and a much weaker inhibitor of Kv4.2 (Yuan et al., 2007) ; HpTx2 inhibits Kv4.2 to roughly the same degree as Kv4.3 (Zarayskiy et al., 2005) . Although it is likely these three toxins interact with Kv4 channels at or near the S3b HpTx2 binding site, this assumption has not been tested experimentally. We have shown differences previously in the affinity of HpTx2 for Kv4.3 associated with an ancillary subunit (DeSimone et al., 2009) ; in this work, we have shown how to distinguish Kv4.1 currents from Kv4.3 (and probably Kv4.2) currents using this toxin. Although we have not tested all combinations of Kv4 channel and ancillary subunit for their current phenotype in response to HpTx2, we believe that this toxin, perhaps in combination with other Kv4-specific peptide toxins, will prove to be useful in unambiguous 
